




























![]()
Q1: 2026-05-07 Earnings Summary
EPS of $0.07 beats by $0.13
|
Revenue of
$150.84M
(-2.61% Y/Y)
beats by $4.28M
10x Genomics, Inc. (TXG) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDT
Company Participants
Cassie Corneau - Manager of Investor Relations & Strategic Finance
Serge Saxonov - Co-Founder, CEO & Director
Adam Taich - CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
Conference Call Participants
Patrick Donnelly - Citigroup Inc., Research Division
Matthew Larew - William Blair & Company L.L.C., Research Division
Madeline Mollman - Wolfe Research, LLC
Mason Carrico - Stephens Inc., Research Division
Luke Sergott - Barclays Bank PLC, Research Division
Kyle Boucher - TD Cowen, Research Division
Kyle Mikson - Canaccord Genuity Corp., Research Division
Thomas VonDerVellen - Guggenheim Securities, LLC, Research Division
Sam Martin - Deutsche Bank AG, Research Division
Puneet Souda - Leerink Partners LLC, Research Division
Priya Patel - Jefferies LLC, Research Division
Paul Stewardson - Stifel, Nicolaus & Company, Incorporated, Research Division
Presentation
Operator
Good afternoon, and welcome to 10x Genomics' First Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
I would now like to turn the call over to Cassie Corneau, Senior Director, Investor Relations and Strategic Finance. Thank you. Please go ahead.
Cassie Corneau
Manager of Investor Relations & Strategic Finance
Thank you, and good afternoon, everyone. Earlier today, 10x Genomics released financial results for the first quarter ended March 31, 2026. If you have not received this news release or would like to be added to the company's distribution list, please send an e-mail to investors@10xgenomics.com. An archived webcast of this call will be available on the Investor tab of the company's website, 10xgenomics.com, for at least 45 days following this call.
Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。